{"id": "1362608311057719301", "creation": 1613706112.0, "user_id": "86970530", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 0, "like_count": 13, "quote_count": 0}}, "quoted": "1362605583917068288", "text": "Important prospective multicenter study (N~900) of #COVID19 mRNA #vaccine in ppl with #cancer has opened to accrual in EU as of Jan 2021: https://t.co/LSRAL7J4XG. Looking forward to seeing this data! #COVIDnCancer #OncTwitter #MedTwitter \n\ncc @EdKimMDLCI @nlinmd @SuannaBruinooge https://t.co/McEi1OiRzt", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#CANCER", "#COVIDNCANCER", "#ONCTWITTER", "#MEDTWITTER"]}